ascopubs.org

Mismatch repair (MMR) and base excision repair (BER) protein expression correlates with clinical response to dacarbazine (DTIC)/temozolomide (TMZ) therapy of patients with ...

Phase II study of the farnesyltransferase inhibitor R115777 in advanced melanoma: CALGB 500104 No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the 2006 ASCO ...
ascopubs.org

Pharmacokinetic profile of the base-excision repair inhibitor methoxyamine-HCl (TRC102; MX) given as an one-hour intravenous infusion with temozolomide (TMZ) in the first-in ...

Fluorescence-guided tumor resection using a telomerase-dependent adenoviral GFP for cancer-specific labeling. Background: MX, the first base excision repair (BER) inhibitor evaluated in humans, blocks ...